Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 42
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus 2023 Urso, LoredanaRaimondi, VittoriaBuldini, BarbaraMinuzzo, Sonia A.D’Agostino, Donna M.Ciminale, Vincenzo + ANTIOXIDANTS - -
Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets 2023 Cavallari, IlariaUrso, Loredana + FRONTIERS IN ONCOLOGY - -
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells 2022 Vittoria RaimondiLoredana UrsoBarbara BuldiniSamuela FrancescatoSonia A. MinuzzoStefano IndraccoloDonna M. D’AgostinoVincenzo Ciminale + REDOX BIOLOGY - -
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial 2022 Dieci, Maria VittoriaGuarneri, ValentinaTosi, AnnaVernaci, Grazia MariaGriguolo, GaiaUrso, LoredanaRosato, AntonioConte, Pierfranco + CLINICAL CANCER RESEARCH - -
P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment 2021 Pezzuto, FedericaLunardi, FrancescaVedovelli, LucaFortarezza, FrancescoUrso, LoredanaFaccioli, EleonoraSchiavon, MarcoGregori, DarioRea, FedericoPasello, GiuliaCalabrese, Fiorella + FRONTIERS IN ONCOLOGY - -
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers 2021 Urso, LoredanaRaimondi, VittoriaD'Agostino, Donna MCiminale, Vincenzo + CANCERS - -
Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification 2021 Urso L.Silic-Benussi M.Bonanno L.Lunardi F.Guarneri V.Calabrese F.Rea F.Conte P.Pasello G. + CYTOKINE - -
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis 2021 Urso L.Vernaci G.Fassan M.Zulato E.Faggioni G.Menichetti A.Di Liso E.Griguolo G.Conte P.Indraccolo S.Guarneri V.Dieci M. V. + FRONTIERS IN ONCOLOGY - -
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 2020 Guarneri, ValentinaGriguolo, GaiaDieci, Maria VUrso, LoredanaMiglietta, FedericaConte, Pierfranco + THE LANCET ONCOLOGY - -
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype 2020 Guarneri, ValentinaDieci, Maria VittoriaGriguolo, GaiaUrso, LoredanaConte, Pierfranco + CLINICAL CANCER RESEARCH - -
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 2020 Dal Maso A.Lorenzi M.Urso L.Frega S.Bonanno L.Indraccolo S.Calabrese F.Conte P.Pasello G. + CLINICAL LUNG CANCER - -
Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer 2020 Boscolo A.Fortarezza F.Lunardi F.Urso L.Menis J.Bonanno L.Guarneri V.Rea F.Conte P.Calabrese F.Pasello G. + FRONTIERS IN ONCOLOGY - -
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2 weeks letrozole: results of the PerELISA neoadjuvant study 2019 Guarneri, VDieci, M VUrso, LGriguolo, GConte, P F + ANNALS OF ONCOLOGY - -
Mesothelin-targeted agents in mesothelioma 2019 Loredana UrsoGiulia Pasello - - Mesothelioma: From Research to Clinical Practice
Targeted therapies in mesothelioma 2019 Loredana UrsoGiulia Pasello - - Mesothelioma: From Research to Clinical Practice
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 2019 Pasello, GiuliaDal Maso, AlessandroLorenzi, MartinaScattolin, DanielaUrso, LoredanaZulato, ElisabettaFrega, StefanoBonanno, LauraIndraccolo, StefanoCalabrese, FiorellaConte, Pierfranco + JOURNAL OF CLINICAL ONCOLOGY - -
Liquid biopsy in malignant pleural mesothelioma: State of the art, pitfalls, and perspectives 2019 Cavallari I.Urso L.Sharova E.Pasello G.Ciminale V. FRONTIERS IN ONCOLOGY - -
Metabolic rewiring and redox alterations in malignant pleural mesothelioma 2019 Urso L.Cavallari I.Sharova E.Ciccarese F.Pasello G.Ciminale V. BRITISH JOURNAL OF CANCER - -
Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intra-tumor heterogeneity over time 2018 Pasello, GLunardi, FUrso, LSchiavon, MPezzuto, FVuljan, S EDel Bianco, PConte, PRea, FCalabrese, F + ANNALS OF ONCOLOGY - -
Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists 2017 URSO, LOREDANACavallari, IlariaSilic-benussi, MicolZago, GiuliaCalabrese, FiorellaConte, PierfrancoCiminale, VincenzoPasello, Giulia + ONCOTARGET - -
Mostrati risultati da 1 a 20 di 42
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile